| Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study L Noens, MA Van Lierde, R De Bock, G Verhoef, P Zachée, Z Berneman, ... Blood, The Journal of the American Society of Hematology 113 (22), 5401-5411, 2009 | 742 | 2009 |
| Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials I Vergote, C Coens, M Nankivell, GB Kristensen, MKB Parmar, T Ehlen, ... The Lancet Oncology 19 (12), 1680-1687, 2018 | 255 | 2018 |
| Lenalidomide maintenance compared with placebo in responding elderly patients with diffuse large B-cell lymphoma treated with first-line rituximab plus cyclophosphamide … C Thieblemont, H Tilly, M Gomes da Silva, RO Casasnovas, C Fruchart, ... Journal of Clinical Oncology 35 (22), 2473-2481, 2017 | 200 | 2017 |
| Endoscopic treatment of stenosis in recurrent Crohn's disease with balloon dilation combined with local corticosteroid injection C Ramboer, M Verhamme, E Dhondt, S Huys, K Van Eygen, L Vermeire Gastrointestinal endoscopy 42 (3), 252-255, 1995 | 158 | 1995 |
| Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial J Trotman, SF Barrington, D Belada, M Meignan, R MacEwan, C Owen, ... The Lancet Oncology 19 (11), 1530-1542, 2018 | 126 | 2018 |
| Imetelstat achieves meaningful and durable transfusion independence in high transfusion–burden patients with lower-risk myelodysplastic syndromes in a phase II study DP Steensma, P Fenaux, K Van Eygen, A Raza, V Santini, U Germing, ... Journal of Clinical Oncology 39 (1), 48-56, 2021 | 98 | 2021 |
| Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study F Morschhauser, S Le Gouill, P Feugier, S Bailly, E Nicolas-Virelizier, ... The Lancet Haematology 6 (8), e429-e437, 2019 | 85 | 2019 |
| Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes M Delforge, D Selleslag, Y Beguin, A Triffet, P Mineur, K Theunissen, ... Leukemia research 38 (5), 557-563, 2014 | 75 | 2014 |
| Determination of an adequate screening tool for identification of vulnerable elderly head and neck cancer patients treated with radio (chemo) therapy L Pottel, T Boterberg, H Pottel, L Goethals, N Van Den Noortgate, ... Journal of geriatric oncology 3 (1), 24-32, 2012 | 71 | 2012 |
| A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B‐cell lymphoma B Coiffier, J Radford, A Bosly, G Martinelli, G Barca, A Davies, D Decaudin, ... British journal of haematology 163 (3), 334-342, 2013 | 59 | 2013 |
| The effect of EUSOMA certification on quality of breast cancer care PA Van Dam, M Tomatis, L Marotti, J Heil, R Wilson, MR Del Turco, ... European Journal of Surgical Oncology (EJSO) 41 (10), 1423-1429, 2015 | 45 | 2015 |
| Time trends (2006–2015) of quality indicators in EUSOMA-certified breast centres PA Van Dam, M Tomatis, L Marotti, J Heil, RE Mansel, MR Del Turco, ... European Journal of Cancer 85, 15-22, 2017 | 37 | 2017 |
| Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial KM Mullane, VA Morrison, LH Camacho, A Arvin, SA McNeil, J Durrand, ... The Lancet Infectious Diseases 19 (9), 1001-1012, 2019 | 29 | 2019 |
| Predictors of baseline cancer‐related cognitive impairment in cancer patients scheduled for a curative treatment M Lycke, L Pottel, H Pottel, L Ketelaars, K Stellamans, K Van Eygen, ... Psycho‐Oncology 26 (5), 632-639, 2017 | 29 | 2017 |
| Organization, quality and cost of oncological home-hospitalization: A systematic review L Cool, D Vandijck, P Debruyne, M Desmedt, T Lefebvre, M Lycke, ... Critical reviews in oncology/hematology 126, 145-153, 2018 | 27 | 2018 |
| First analysis of an international double-blind randomized phase III study of lenalidomide maintenance in elderly patients with DLBCL treated with R-CHOP in first line, the … C Thieblemont, H Tilly, MG da Silva, RO Casasnovas, C Fruchart, ... Blood 128 (22), 471, 2016 | 27 | 2016 |
| Prediction of non-sentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node A Reynders, O Brouckaert, A Smeets, A Laenen, E Yoshihara, F Persyn, ... the Breast 23 (4), 453-459, 2014 | 26 | 2014 |
| Subjective, but not objective, cognitive complaints impact long-term quality of life in cancer patients M Lycke, T Lefebvre, L Pottel, H Pottel, L Ketelaars, K Stellamans, ... Journal of Psychosocial Oncology 37 (4), 427-440, 2019 | 24 | 2019 |
| Obinutuzumab plus Lenalidomide (GALEN) for the treatment of relapse/refractory aggressive lymphoma: a phase II LYSA study R Houot, G Cartron, F Bijou, S De Guibert, GA Salles, C Fruchart, ... Leukemia 33 (3), 776-780, 2019 | 22 | 2019 |
| The use of uHear™ to screen for hearing loss in older patients with cancer as part of a comprehensive geriatric assessment M Lycke, PR Debruyne, T Lefebvre, E Martens, L Ketelaars, H Pottel, ... Acta Clinica Belgica 73 (2), 132-138, 2018 | 22 | 2018 |
